EGFR and prostate carcinoma: Interestingly, it has been reported that AGK overexpression promotes aggressiveness in prostate cancer cells through activation of EGFR, and that upregulation of AGK promotes the stem cell-like phenotype in ESCC by sustaining JAK2 activity[15,22].